Center-Authored Papers

Filters: Author is Abkowitz, Janis L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Tretinoin
Oehler VG, Guthrie KA, Cummings CL, Sabo K, Wood BL, Gooley TA, Yang T, Epping MT, Shou Y, Pogosova-Agadjanyan E et al..  2009.  The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells.. Blood. 114(15):3299-308. Abstract
Transduction, Genetic
Doty RT, Sabo KM, Chen J, Miller AD, Abkowitz JL.  2010.  An all-feline retroviral packaging system for transduction of human cells.. Human gene therapy. 21(8):1019-27. Abstract
Thrombocytopenia
Zhang MY, Churpek JE, Keel SB, Walsh T, Lee MK, Loeb KR, Gulsuner S, Pritchard CC, Sanchez-Bonilla M, Delrow JJ et al..  2015.  Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.. Nature genetics. 47(2):180-5. Abstract
T-Lymphocytes
Philip M, Funkhouser SA, Chiu EY, Phelps SR, Delrow JJ, Cox J, Fink PJ, Abkowitz JL.  2015.  Heme exporter FLVCR is required for T cell development and peripheral survival.. Journal of immunology (Baltimore, Md. : 1950). 194(4):1677-85. Abstract
Specimen Processing Core Facility
Buckley SA, Othus M, Vainstein V, Abkowitz JL, Estey EH, Walter RB.  2014.  Prediction of adverse events during Intensive Induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.. American journal of hematology. 89(4):423-8. Abstract
Shared Resources
Buckley SA, Othus M, Vainstein V, Abkowitz JL, Estey EH, Walter RB.  2014.  Prediction of adverse events during Intensive Induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.. American journal of hematology. 89(4):423-8. Abstract
Keel SB, Doty RT, Yang Z, Quigley JG, Chen J, Knoblaugh SE, Kingsley PD, De Domenico I, Vaughn MB, Kaplan J et al..  2008.  A heme export protein is required for red blood cell differentiation and iron homeostasis.. Science (New York, N.Y.). 319(5864):825-8. Abstract
Sequence Analysis, RNA
Zhang MY, Churpek JE, Keel SB, Walsh T, Lee MK, Loeb KR, Gulsuner S, Pritchard CC, Sanchez-Bonilla M, Delrow JJ et al..  2015.  Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.. Nature genetics. 47(2):180-5. Abstract
Reverse Transcriptase Polymerase Chain Reaction
Philip M, Funkhouser SA, Chiu EY, Phelps SR, Delrow JJ, Cox J, Fink PJ, Abkowitz JL.  2015.  Heme exporter FLVCR is required for T cell development and peripheral survival.. Journal of immunology (Baltimore, Md. : 1950). 194(4):1677-85. Abstract
Research Trials Office Core Facility - Biostatistics Service
Becker PS, Medeiros BC, Stein AS, Othus M, Appelbaum FR, Forman SJ, Scott BL, Hendrie PC, Gardner KM, Pagel JM et al..  2015.  G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.. American journal of hematology. 90(4):295-300. Abstract
Buckley SA, Othus M, Vainstein V, Abkowitz JL, Estey EH, Walter RB.  2014.  Prediction of adverse events during Intensive Induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.. American journal of hematology. 89(4):423-8. Abstract
Repressor Proteins
Zhang MY, Churpek JE, Keel SB, Walsh T, Lee MK, Loeb KR, Gulsuner S, Pritchard CC, Sanchez-Bonilla M, Delrow JJ et al..  2015.  Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.. Nature genetics. 47(2):180-5. Abstract
Red-Cell Aplasia, Pure
Keel SB, Doty RT, Yang Z, Quigley JG, Chen J, Knoblaugh SE, Kingsley PD, De Domenico I, Vaughn MB, Kaplan J et al..  2008.  A heme export protein is required for red blood cell differentiation and iron homeostasis.. Science (New York, N.Y.). 319(5864):825-8. Abstract
Recombinant Proteins
Zhang MY, Churpek JE, Keel SB, Walsh T, Lee MK, Loeb KR, Gulsuner S, Pritchard CC, Sanchez-Bonilla M, Delrow JJ et al..  2015.  Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.. Nature genetics. 47(2):180-5. Abstract
Receptors, Virus
Doty RT, Sabo KM, Chen J, Miller AD, Abkowitz JL.  2010.  An all-feline retroviral packaging system for transduction of human cells.. Human gene therapy. 21(8):1019-27. Abstract
Philip M, Funkhouser SA, Chiu EY, Phelps SR, Delrow JJ, Cox J, Fink PJ, Abkowitz JL.  2015.  Heme exporter FLVCR is required for T cell development and peripheral survival.. Journal of immunology (Baltimore, Md. : 1950). 194(4):1677-85. Abstract
Keel SB, Doty RT, Yang Z, Quigley JG, Chen J, Knoblaugh SE, Kingsley PD, De Domenico I, Vaughn MB, Kaplan J et al..  2008.  A heme export protein is required for red blood cell differentiation and iron homeostasis.. Science (New York, N.Y.). 319(5864):825-8. Abstract
Real-Time Polymerase Chain Reaction
Philip M, Funkhouser SA, Chiu EY, Phelps SR, Delrow JJ, Cox J, Fink PJ, Abkowitz JL.  2015.  Heme exporter FLVCR is required for T cell development and peripheral survival.. Journal of immunology (Baltimore, Md. : 1950). 194(4):1677-85. Abstract
Public Health Sciences Division
Buckley SA, Othus M, Vainstein V, Abkowitz JL, Estey EH, Walter RB.  2014.  Prediction of adverse events during Intensive Induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.. American journal of hematology. 89(4):423-8. Abstract
Proto-Oncogene Proteins c-ets
Zhang MY, Churpek JE, Keel SB, Walsh T, Lee MK, Loeb KR, Gulsuner S, Pritchard CC, Sanchez-Bonilla M, Delrow JJ et al..  2015.  Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.. Nature genetics. 47(2):180-5. Abstract
Proto-Oncogene Proteins c-abl
Oehler VG, Guthrie KA, Cummings CL, Sabo K, Wood BL, Gooley TA, Yang T, Epping MT, Shou Y, Pogosova-Agadjanyan E et al..  2009.  The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells.. Blood. 114(15):3299-308. Abstract
Protein Structure, Tertiary
Zhang MY, Churpek JE, Keel SB, Walsh T, Lee MK, Loeb KR, Gulsuner S, Pritchard CC, Sanchez-Bonilla M, Delrow JJ et al..  2015.  Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.. Nature genetics. 47(2):180-5. Abstract
Protein Kinase Inhibitors
Oehler VG, Guthrie KA, Cummings CL, Sabo K, Wood BL, Gooley TA, Yang T, Epping MT, Shou Y, Pogosova-Agadjanyan E et al..  2009.  The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells.. Blood. 114(15):3299-308. Abstract
Prognosis
Oehler VG, Guthrie KA, Cummings CL, Sabo K, Wood BL, Gooley TA, Yang T, Epping MT, Shou Y, Pogosova-Agadjanyan E et al..  2009.  The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells.. Blood. 114(15):3299-308. Abstract
Pedigree
Zhang MY, Churpek JE, Keel SB, Walsh T, Lee MK, Loeb KR, Gulsuner S, Pritchard CC, Sanchez-Bonilla M, Delrow JJ et al..  2015.  Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.. Nature genetics. 47(2):180-5. Abstract